galeterone [Ligand Id: 8638] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL2105738 (Galeterone, TOK 001, TOK-001, VN 124, VN-124, VN/124, VN/124-1)
  • Androgen receptor/Androgen Receptor in Human [ChEMBL: CHEMBL1871] [GtoPdb: 628] [UniProtKB: P10275]
There should be some charts here, you may need to enable JavaScript!
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
Androgen receptor/Androgen Receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1871] [GtoPdb: 628] [UniProtKB: P10275]
GtoPdb - - 6.42 pIC50 384 nM IC50 J Med Chem (2005) 48: 2972-84 [PMID:15828836]
ChEMBL Displacement of [3H]R1881 from androgen receptor in human LNCAP cells B 6.07 pEC50 845 nM EC50 J Med Chem (2015) 58: 2077-2087 [PMID:25591066]
ChEMBL Displacement of [3H]R1881 from AR in human LNCaP cells after 2 hrs by scintillation counting analysis B 6.17 pEC50 670 nM EC50 J Med Chem (2013) 56: 4880-4898 [PMID:23713567]
ChEMBL Displacement of [3H]R1881 from androgen receptor in human PC3 cells B 6.39 pEC50 405 nM EC50 J Med Chem (2015) 58: 2077-2087 [PMID:25591066]
CYP17A1/Cytochrome P450 17A1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3522] [GtoPdb: 1361] [UniProtKB: P05093]
ChEMBL Inhibition of human truncated CYP17A1 expressed in Escherichia coli B 6.12 pIC50 752 nM IC50 J Med Chem (2013) 56: 4880-4898 [PMID:23713567]
GtoPdb - - 6.52 pIC50 300 nM IC50 J Med Chem (2005) 48: 2972-84 [PMID:15828836]
ChEMBL Inhibition of human CYP17 expressed in Escherichia coli B 6.52 pIC50 300 nM IC50 J Med Chem (2015) 58: 2077-2087 [PMID:25591066]
ChEMBL Inhibition of human membrane bound C-terminal His4-tagged CYP17A1 delta19H mutant assessed as reduction in progesterone hydroxylation preincubated for 3 mins followed by NADPH addition measured after 10 mins in presence of NADPH-cytochrome p450 reductase by HPLC method B 6.55 pIC50 282 nM IC50 US-20160031929-A1. Inhibitors of cyp17a1 (null)
ChEMBL Inhibition of CYP17 (unknown origin) B 6.85 pIC50 140 nM IC50 ACS Med Chem Lett (2016) 7: 708-713 [PMID:27437082]
ChEMBL Inhibition of C-terminal His-tagged recombinant human CYP17A1delta19H mutant expressed in Escherichia coli DH5alpha assessed as decrease in progesterone hydroxylation preincubated for 3 mins followed by NADPH addition measured after 10 mins in presence of cytochrome p450 reductase by LC-MS/MS method B 7.55 pIC50 28.1 nM IC50 J Med Chem (2018) 61: 4946-4960 [PMID:29792703]

ChEMBL data shown on this page come from version 33:

Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]